SUPN — Recent News Coverage
All news mentioning SUPN in ESEN's AI-graded feed
News stories with SUPN as an affected ticker. Each article is graded by ESEN AI for impact level and direction (up/down/flat) on SUPN. See /coverage/SUPN for the 30-day aggregate.
FINANCE.YAHOO.COM
·
2026-08-04
NEUTRAL
NEUTRAL
CORR0.42
Supernus and Indivior merge to create scaled, CNS-focused entity
$SUPN
$INVA
◈ ESEN AI
Supernus Pharmaceuticals and Indivior are combining operations to establish a scaled pharmaceutical entity with concentrated expertise in central nervous system (CNS) disorders and opioid use disorder (OUD) treatments. …
SEEKINGALPHA.COM
·
2026-08-03
HIGH
BULLISH
CORR0.72
Supernus Pharmaceuticals, Inc. (SUPN) M&A Call Transcript
$SUPN
◈ ESEN AI
Supernus Pharmaceuticals (SUPN) disclosed M&A activity through an official earnings call transcript, signaling corporate action that typically triggers equity volatility and investor repositioning. M&A announcements rep…
SEEKINGALPHA
·
2026-08-03
NEUTRAL
BULLISH
CORR0.42
Supernus, Indivior stock jumps after all-stock deal to merge
$SUPN
$INDV
◈ ESEN AI
SUPN and INDV announced an all-stock merger, triggering immediate positive price action in both equities. All-stock deals typically signal management confidence in valuation multiples while avoiding cash drain, though e…
MANILATIMES.NET
·
2026-08-03
HIGH
BULLISH
CORR0.72
Supernus Announces Second Quarter 2026 Financial Results
$SUPN
$INDV
◈ ESEN AI
Supernus Pharmaceuticals delivered a 32% revenue beat in Q2 2026, with core growth products surging 52% year-over-year to $175.7M. This acceleration reflects strong commercial execution across the CNS portfolio, particu…
MANILATIMES.NET
·
2026-08-03
HIGH
BULLISH
CORR0.72
Supernus Pharmaceuticals and Indivior Pharmaceuticals to Merge, Creating a Diversified CNS Biopharmaceutical Leader with Significant Scale
$SUPN
$INDV
◈ ESEN AI
Supernus Pharmaceuticals (SUPN) and Indivior announced a merger creating a combined CNS biopharmaceutical entity with approximately $2.2 billion in annual revenues. This transaction represents a significant consolidatio…
GLOBALNEWSWIRE
·
2026-08-03
HIGH
BULLISH
CORR0.72
Supernus Pharmaceuticals and Indivior Pharmaceuticals to Merge, Creating a Diversified CNS Biopharmaceutical Leader with Significant Scale
$SUPN
$INDV
◈ ESEN AI
The all-stock merger between Supernus Pharmaceuticals (SUPN) and Indivior Pharmaceuticals (INDV) represents a significant consolidation event in the CNS biopharmaceutical sector. This combination creates a scaled divers…
MANILATIMES.NET
·
2026-06-17
LOW
BULLISH
CORR0.42
Supernus Expands Partnership With MERGE as AI-Powered Agency of Record
$SUPN
◈ ESEN AI
Supernus Pharmaceuticals (SUPN) announced an expanded partnership with MERGE, designating the agency as its artificial intelligence-powered agency of record. This strategic broadening of an existing relationship reflect…
EXPLORE OTHER FILTERS